Moderna, Merck begin late-stage study for mRNA cancer therapy

1 year ago 66

Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with blockbuster drug Keytruda for patients with a type of lung cancer.

1. Homepage
2. Cancer
3. Moderna, Merck begin late-stage study for mRNA cancer therapy